NASDAQ:ACRS | Operating Income | Aclaris Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$24.24M
2026-03-31-$22.19M
2025-12-31-$22.73M
2025-09-30-$17.15M
2025-06-30-$18.41M
2025-03-31-$18.08M
2024-12-31-$99.68M
2024-09-30-$10.47M
2024-06-30-$12.85M
2024-03-31-$18.93M
2023-12-31-$4.05M
2023-09-30-$31.58M
2023-06-30-$31.82M
2023-03-31-$29.92M
2022-12-31-$29.08M
2022-09-30-$20.87M
2022-06-30-$20.99M
2022-03-31-$18.91M
2021-12-31-$22.89M
2021-09-30-$20.3M
2021-06-30-$18.01M
2021-03-31-$28.53M
2020-12-31-$13.56M
2020-09-30-$10.47M
2020-06-30-$11.38M
2020-03-31-$15.51M
2019-12-31-$17.55M
2019-09-30-$22.86M
2019-06-30-$43.6M
2019-03-31-$27.05M
2018-12-31-$24.04M
2018-09-30-$21.34M
2018-06-30-$31.98M
2018-03-31-$30.95M
2017-12-31-$7.38M
2017-09-30-$18.76M
2017-06-30-$15.3M
2017-03-31-$12.93M
2016-12-31-$11.63M
2016-09-30-$10.81M
2016-06-30-$12.99M
2016-03-31-$13.14M
2015-12-31-$4.8M
2015-09-30-$10.64M
2015-06-30-$2.6M
2015-03-31-$2.63M
2014-12-31-$2.6M
2014-09-30-$2.66M

Annual Operating Income

DateOperating Income
2025-12-31-$76.38M
2024-12-31-$141.93M
2023-12-31-$97.36M
2022-12-31-$89.85M
2021-12-31-$89.72M
2020-12-31-$50.91M
2019-12-31-$111.06M
2018-12-31-$84.78M
2017-12-31-$54.36M
2016-12-31-$48.57M
2015-12-31-$20.67M
2014-12-31-$8.53M
2013-12-31-$5.26M